[1] Brunton L, Hall S, Passingham A, et al. The prevalence, location, severity, and daily impact of pain reported by youth and young adults with cerebral palsy [J]. J Pediatr Rehabil Med, 2016, 9(3): 177-183. [2] Durkin MS, Benedict RE, Christensen D, et al. Prevalence of cerebral palsy among 8-year-old children in 2010 and preliminary evidence of trends in its relationship to low birthweight [J]. Paediatr Perinat Epidemiol, 2016, 30(5): 496-510. [3] Mongan D, Dunne K, O'Nuallain S, et al. Prevalence of cerebral palsy in the West of Ireland. 1990-1999 [J]. Dev Med Child Neurol, 2006, 48(11): 892-895. [4] Platt MJ, Cans C, Johnson A, et al. Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study [J]. Lancet, 2007, 369(9555): 43-50. [5] Hawamdeh ZM, Ibrahim AI, Qudah AAL. Long term effect of Botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy [J]. Eura Medicophysica, 2007, 43(3): 311-318. [6] Matthews JD, Balaban B. Management of spasticity in children with cerebral palsy [J]. Acta Orthop Traumatol Turc, 2009, 43(2): 81-86. [7] Brouwer B, Davidson LK, Olney SJ. Serial casting in idiopathic toe-walkers and children with spastic cerebral palsy [J]. J Pediatr Orthop, 2000, 20(2): 221-225. [8] McNee AE, Will E, Lin JP, et al. The effect of serial casting on gait in children with cerebral palsy: preliminary Results from a crossover trial [J]. Gait Posture, 2007, 25(3): 463-468. [9] Unlu E, Cevikol A, Bal B, et al. Multilevel Botulinum toxin type A as a treatment for spasticity in children with cerebral palsy: a retrospective study [J]. Clinics (Sao Paulo), 2010, 65(6): 613-619. [10] 林庆. 小儿脑性瘫痪的定义、诊断条件及分型[J]. 中华儿科杂志, 2005, 43(4): 262. [11] Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity [J]. Phys Ther, 1987, 67(2): 206-207. [12] Albavera-Hernandez C, Rodriguez J, Idrovo AJ. Safety of Botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomised clinical trials [J]. Clin Rehabil, 2009, 23(5): 394-407. [13] Son SM, Park IS, Yoo JS. Short-term effect of Botulinum toxin A injection on spastic equinovarus foot in cerebral palsy patients: a study using the foot pressure measurement system [J]. Ann Rehabil Med, 2015, 39(1): 1-9. [14] Colovic H, Dimitrijevic L, Stankovic I, et al. The effects of Botulinum toxin type A on improvement and dynamic spastic equinus correction in children with cerebral palsy–preliminary Results [J]. Arch Med Sci, 2014, 10(5): 979-984. [15] Mirska A, Cybula K, Okurowska-Zawada B, et al. Use of Botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy [J]. J Pediatr Orthop B, 2014, 23(6): 517-522. [16] Choi JY, Jung S, Rha DW, et al. Botulinum toxin type A injection for spastic equinovarus foot in children with spastic cerebral palsy: effects on gait and foot pressure distribution [J]. Yonsei Med J, 2016, 57(2): 496-504. [17] Edwards P, Sakzewski L, Copeland L, et al. Safety of Botulinum toxin type A for children with nonambulatory cerebral palsy [J]. Pediatrics, 2015, 136(5): 895-904. [18] Dursun N, Gokbel T, Akarsu M, et al. A randomized controlled trial on effectiveness of intermittent serial casting on spastic equinus foot in children with cerebral palsy after Botulinum toxin-A treatment [J]. Am J Phys Med Rehabil, 2017, 96(4): 221-225. [19] Pavone V, Testa G, Restivo DA, et al. Botulinum toxin treatment for limb spasticity in childhood cerebral palsy [J]. Front Pharmacol, 2016, 7: 29. [20] Booth MY, Yates CC, Edgar TS, et al. Serial casting vs combined intervention with Botulinum toxin A and serial casting in the treatment of spastic equinus in children [J]. Pediatr Phys Ther, 2003, 15(4): 216-220. [21] García-Sánchez SF, Gómez-Galindo MT, Guzmán-Pantoja JE. Botulinum toxin A and physical therapy in gait in cerebral palsy [J]. Rev Med Inst Mex Seguro Soc, 2017, 55(1): 18-24. [22] Mietton C, Schaeffer L, Streichenberger N, et al. Physiological anatomy of Botulinum toxin effect on the spastic muscle of children with cerebral palsy [J]. Ann Phys Rehabil Med, 2016, 59S: e6 |